Atezolizumab plus Bevacizumab with or without Transarterial Chemoembolization as First-Line Treatment for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma: A Nationwide Multicenter Retrospective Study.
Overview & Synopsis
Open access biomedical research article published in Liver Cancer.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Atezolizumab plus Bevacizumab with or without Transarterial Chemoembolization as First-Line Treatment for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma: A Nationwide Multicenter Retrospective Study. |
|---|---|
| Author / Organization | Zhang XW, Deng LW, Luo YG, Xie YF, Liu RB, Shao HB, Si TG, Feng DP, Wang J, Zhang Y, Li QD, Hu HT, Fan WJ, Song P, Yin LN, Wang Y, Chen Y, Lv TS, Xie Y, Hua TY, Xiao J, Nie RC, Shen LJ, Xuan ZM, Liu C, Yang XG, Chang X, Li X |
| Subject & Discipline | Liver Cancer |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-50040 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |